US pharma AbbVie has put compatriot Allergan’s women’s health business up for sale. The company is said to be working with Morgan Stanley on an auction process that has...
US biopharma AbbVie and compatriot biotech Caribou Biosciences have entered into a multi-year collaboration and license agreement to research and develop chimeric antigen...
US biopharma AbbVie has signed a global collaboration agreement with China’s I-Mab to develop and commercialize lemzoparlimab – also known as TJC4 – an anti-CD47...
17.06.2020
- US drugmaker AbbVie has signed two separate collaboration agreements, one with Denmark’s Genmab and the other with China’s Jacobio Pharmaceuticals, for developing and...
17.01.2020
- Japanese drugmaker Takeda is facing a large tax bill from Ireland as an uncalculated repercussion of its acquisition of US-managed, Ireland-domiciled Shire at the end of 2018. Tax...
04.10.2019
- The US Federal Trade Commission (FTC) has requested additional information from both Allergan and AbbVie as it digs deeper into the proposed merger of the two drugmakers. Biopharma...
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
27.06.2019
- In a deal expected to close early next year, US biopharma AbbVie is buying troubled Botox manufacturer Allergan for $63 billion in cash and shares. The acquisition is the second...
